Prostate Cancer

Compared with systematic biopsy, MRI-directed targeted biopsy reduces the risk of overdiagnosis of prostate cancer for men with elevated prostate-specific antigen levels, according to researchers.

Lutetium Lu 177 vipivotide tetraxetan improved radiographic PFS compared with androgen receptor pathway inhibitor therapy among certain men with pretreated prostate cancer, according to the agent’s manufacturer.

In a systemic review and meta-analysis, statin therapy during androgen-ablative therapies was associated with a potential mortality benefit for men being treated for prostate cancer.

Androgen deprivation therapy sequencing had a considerable effect on outcomes among men with prostate cancer who received prostate-only radiotherapy, according to study results published in Journal of Clinical Oncology.

Prostate cancer clinical trials included significant underrepresentation of Asian, Black and Hispanic men based on incidence of the disease among these groups, results of meta-analysis published in JAMA Oncology showed.

Jansen Biotech said its drug Tecvayli received accelerated approval from the FDA after data showed that it benefited patients with relapsed or refractory multiple myeloma.

Adding localized radiation therapy to intermittent hormone therapy extended PFS among men with oligometastatic prostate cancer, data from the randomized phase 2 EXTEND trial showed.

Men with high-risk prostate cancer who received a shorter course of radiation therapy had similar survival and recurrence rates as those who received a longer, standard radiation therapy course, phase 3 trial results showed.

Delayed care and legal concerns are among clinicians’ primary concerns following the Dobbs v. Jackson Women’s Health Organization decision, which gave states the right to decide the legality of abortion within their borders.

High coffee consumption appeared associated with increased prostate cancer-specific survival among men with a CYP1A2 AA caffeine metabolism genotype, according to study results published in European Association of Urology.